KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) EPS (Basic) (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 2.36%
Dec 28, 2025 -0.93%
Sep 28, 2025 -6.96%
Jun 29, 2025 -49.67%
Mar 30, 2025 221.83%
Dec 29, 2024 26.79%
Sep 29, 2024 -42.56%
Jun 30, 2024 44.44%
Mar 31, 2024 -19.64%
Dec 31, 2023 -83.72%
Oct 1, 2023 421.21%
Jul 2, 2023 6,700.00%
Apr 2, 2023 -102.22%
Jan 1, 2023 -20.59%
Oct 2, 2022 -7.10%
Jul 3, 2022 5.17%
Oct 3, 2021 -41.60%
Jul 4, 2021 1.28%
Apr 4, 2021 256.06%
Jan 3, 2021 -51.11%
Sep 27, 2020 -2.17%
Jun 28, 2020 -37.27%
Mar 29, 2020 44.74%
Dec 29, 2019 126.87%
Sep 29, 2019 -68.25%
Jun 30, 2019 49.65%
Mar 31, 2019 23.68%
Dec 30, 2018 -22.45%
Sep 30, 2018 0.00%
Jul 1, 2018 -9.82%
Apr 1, 2018 140.85%
Dec 31, 2017 -385.00%
Oct 1, 2017 -1.41%
Jul 2, 2017 -12.88%
Apr 2, 2017 15.60%
Jan 1, 2017 -9.62%
Oct 2, 2016 6.85%
Jul 3, 2016 -9.88%
Apr 3, 2016 39.66%
Jan 3, 2016 -4.13%
Sep 27, 2015 -25.77%
Jun 28, 2015 5.16%
Mar 29, 2015 72.22%
Dec 28, 2014 -46.75%
Sep 28, 2014 10.46%
Jun 29, 2014 -8.38%
Mar 30, 2014 33.60%
Dec 29, 2013 17.92%
Sep 29, 2013 -22.06%
Jun 30, 2013 8.80%
Mar 31, 2013 34.41%
Dec 30, 2012 -13.89%
Sep 30, 2012 111.76%
Jul 1, 2012 -64.34%
Apr 1, 2012 1,687.50%
Jan 1, 2012 -93.16%
Oct 2, 2011 15.84%
Jul 3, 2011 -20.47%
Apr 3, 2011 78.87%
Jan 2, 2011 -42.74%
Oct 3, 2010 -0.80%
Jul 4, 2010 -23.78%
Apr 4, 2010 105.00%
Jan 3, 2010 -33.88%
Sep 27, 2009 4.31%
Jun 28, 2009 -8.66%